Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy

Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy

Josefina Marin, María Laura Acosta Felquer, Enrique R Soriano Rheumatology Unit, Internal Medical Serivces, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina Abstract: Certolizumab pegol (CZP) is a pegylated huma...

Full description

Saved in:
Bibliographic Details
Main Authors: Marin J, Acosta Felquer ML, Soriano ER
Format: article
Language:EN
Published: Dove Medical Press 2018
Subjects:
certolizumab pegol
tumor necrosis factor-α inhibitors
ankylosing spondilitys
non-radiographic axial spondyloarthritis
efficacy
safety
Diseases of the musculoskeletal system
RC925-935
Online Access:https://doaj.org/article/d7db2130f257427ab00260fb3fb0170b
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/d7db2130f257427ab00260fb3fb0170b

Similar Items